Ameriprise Financial Inc Orchard Therapeutics PLC Transaction History

Ameriprise Financial Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$1.16 - $2.23 $65,072 - $125,096	-56,097 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$2.24 - $4.29 $40,920 - $78,369	-18,268 Reduced 24.57%	56,097 $129,000
Q2 2021 Aug 16, 2021	BUY	$4.39 - $7.23 $29,254 - $48,180	6,664 Added 9.84%	74,365 $327,000
Q1 2021 May 17, 2021	SELL	$4.39 - $9.08 $55,199 - $114,171	-12,574 Reduced 15.66%	67,701 $491,000
Q4 2020 Feb 12, 2021	SELL	$3.86 - $5.07 $10,676 - $14,023	-2,766 Reduced 3.33%	80,275 $347,000
Q3 2020 Nov 16, 2020	BUY	$4.11 - $6.45 $55,711 - $87,429	13,555 Added 19.51%	83,041 $342,000
Q2 2020 Aug 14, 2020	BUY	$5.75 - $11.99 $399,544 - $833,137	69,486 New	69,486 $417,000

545K

Ticker ORTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,458,000
Description
Orchard Therapeutics plc, a biopharmaceutical company, develops gene therapies for serious and life-threatening rare diseases in the United Kingdom, European Union, and the United States. The company's gene therapy approach seeks to transform a patient's hematopoietic stem cells into a gene-modified cellular drug product to treat the patient's d...

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

Stay updated on Ameriprise Financial Inc with notifications on news.